The photocatalytic degradation of the valsartan (VLS) pharmaceutical using TiO
2 and g-C
3N
4 catalysts under simulated solar light is studied in this paper by high-resolution Orbitrap mass spectrometry.
•OH radicals were the major oxidant species for the degradation of
[...] Read more.
The photocatalytic degradation of the valsartan (VLS) pharmaceutical using TiO
2 and g-C
3N
4 catalysts under simulated solar light is studied in this paper by high-resolution Orbitrap mass spectrometry.
•OH radicals were the major oxidant species for the degradation of valsartan using TiO
2, while positive holes (h
+), followed by a much lesser amount of
•OH radicals, were the major species in the case of g-C
3N
4. Valsartan degradation followed first order kinetics by both catalysts with TiO
2 being the catalyst with the better photocatalytic efficiency. The transformation products (TPs) and their evolution profiles are identified and monitored, respectively, by means of LC-HRMS. Based on TPs identification, the degradation mechanisms are discussed. The major degradation pathways for g-C
3N
4 include decarboxylation and subsequent oxidation, hydroxylation, and cleavage of C–N bond, while for TiO
2 cyclization, TPs are abundant and the hydroxylation occurs in the first stage products. The study highlights the complex nature of TPs formed during such processes, the different mechanisms involved and the necessity for the identification of TPs for the assessment of the treatment and the tracking of such TPs in different environmental compartments.
Full article